Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Published Online: 2004-01-25
Journal: Nature Medicine•Publisher: Springer Science and Business Media LLC
Authors: Alan C Hartford•Alan J Fischman•Andrew X Zhu•Christopher G Willett•Dan G Duda•Daniel C Chung•David P Ryan•David T Scadden•Dushyant V Sahani•Emmanuelle di Tomaso•Gregory Y Lauwers•Helen X Chen•Jeffrey W Clark•Kenneth S Cohen•Lance L Munn•Lawrence S Blaszkowsky•Mari Mino•Paul C Shellito•Rakesh K Jain•Ricky T Tong•Sanjeeva P Kalva•Sergey V Kozin•Yves Boucher
